MARKET

ILMN

ILMN

Illumina
NASDAQ

Real-time Quotes | Nasdaq Last Sale

273.12
-3.11
-1.13%
After Hours: 270.00 -3.12 -1.14% 18:48 03/31 EDT
OPEN
271.35
PREV CLOSE
276.23
HIGH
276.06
LOW
267.90
VOLUME
1.69M
TURNOVER
--
52 WEEK HIGH
380.76
52 WEEK LOW
196.78
MARKET CAP
40.15B
P/E (TTM)
40.55
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ILMN and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 20 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average ILMN stock price target is 319.69 with a high estimate of 371.00 and a low estimate of 220.00.

EPS

ILMN News

More
  • Wells Fargo Maintains Underweight on Illumina, Lowers Price Target to $245
  • Benzinga · 1d ago
  • EXEL vs. ILMN: Which Stock Should Value Investors Buy Now?
  • Zacks · 03/24 16:40
  • Illumina (ILMN) Stock Moves -1.75%: What You Should Know
  • Zacks · 03/23 22:50
  • 26 Benjamin Graham-inspired stock picks
  • Seeking Alpha - Article · 03/23 13:19

Industry

Advanced Medical Equipment & Technology
-1.14%
Healthcare Equipment & Supplies
-0.61%

Hot Stocks

Symbol
Price
%Change

About ILMN

Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc. (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations. Core Illumina's products and services serve customers in the research, clinical and applied markets, and enable the adoption of a range of genomic solutions. The Company's portfolio of integrated systems, consumables and analysis tools addresses the range of genomic complexity, price points, and throughput, enabling customers to select the solution for their research or clinical challenge. The Company provides reproductive-health solutions, including noninvasive prenatal testing (NIPT), preimplantation genetic screening and diagnosis, and neonatal and genetic health testing.
More

Webull offers kinds of Illumina, Inc. stock information, including NASDAQ:ILMN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ILMN stock news, and many more online research tools to help you make informed decisions.